![Scott Chouinard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Scott Chouinard
Comptroller/Controller/Auditor bei FORRESTER RESEARCH, INC.
Vermögen: 143 452 $ am 31.05.2024
Profil
Scott R.
Chouinard is currently working as the Treasurer & Chief Accounting Officer at Forrester Research, Inc. He previously worked as a Controller at EPIX Pharmaceuticals, Inc. Mr. Chouinard completed his undergraduate degree at Merrimack College.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
FORRESTER RESEARCH, INC.
0,04% | 01.03.2024 | 7 974 ( 0,04% ) | 143 452 $ | 31.05.2024 |
Aktive Positionen von Scott Chouinard
Unternehmen | Position | Beginn |
---|---|---|
FORRESTER RESEARCH, INC. | Comptroller/Controller/Auditor | 19.11.2009 |
Ehemalige bekannte Positionen von Scott Chouinard
Unternehmen | Position | Ende |
---|---|---|
EPIX Pharmaceuticals, Inc.
![]() EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Comptroller/Controller/Auditor | - |
Ausbildung von Scott Chouinard
Merrimack College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
FORRESTER RESEARCH, INC. | Commercial Services |
Private Unternehmen | 1 |
---|---|
EPIX Pharmaceuticals, Inc.
![]() EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |